Atlas Trials

Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis

Clinical trial NCT01184833 · COMPLETED

Trial details

NCT number
NCT01184833
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2008-09-01
Enrollment
852

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.